ArticleCancers2026
Circulating Adipokines, Tissue Receptor Expression, and Body Composition: Clinical Relevance and Disease Stage in Epithelial Ovarian Carcinoma.
Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
BACKGROUND/
objectivesNutritional status and adipose tissue-derived mediators have been implicated in the development and clinical characteristics of epithelial ovarian carcinoma; however, studies integrating circulating adipokines, adipokine receptor expression, and nutritional status remain limited. This study aimed to evaluate circulating adipokine concentrations, adipokine receptor expression, nutritional status parameters, and their associations with clinically relevant features and disease stage in women with epithelial ovarian carcinoma.
methodsA total of 151 women were included, comprising 43 patients with epithelial ovarian carcinoma, 89 with benign ovarian tumors, and 19 healthy controls. The nutritional status parameters included body composition, dietary intake, and serum glucose concentration. Circulating adipokines were quantified by ELISA, whereas adipokine receptor expression was evaluated by automated immunohistochemistry in patients with available tumor tissue. Associations with clinicopathological variables were assessed using correlation analyses and multivariable regression models.
resultsCompared with women with benign ovarian tumors, women with epithelial ovarian carcinoma had significantly lower circulating leptin concentrations, whereas their circulating resistin concentrations were significantly higher than in healthy controls. In multivariable analysis, lower leptin and higher resistin concentrations were associated with clinical disease classification, while lower leptin was also associated with advanced-stage disease. Visceral fat was associated with clinical disease classification. In addition, AdipoR1 expression was significantly more frequent in malignant than in benign ovarian tumors.
conclusionsCirculating leptin and resistin, visceral fat, and AdipoR1 expression were associated with clinically relevant characteristics across the study groups. Together, these findings provide a more comprehensive characterization of the metabolic and inflammatory alterations associated with epithelial ovarian carcinoma and may contribute to the identification of potential clinically relevant markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.